{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:48:49Z","timestamp":1777488529596,"version":"3.51.4"},"reference-count":46,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81060085"],"award-info":[{"award-number":["81060085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To observe relationships between oral <jats:italic>Candida<\/jats:italic> status and salivary human beta\u2010defensin 2 and 3 (<jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20102 and <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20103) levels in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content> patients of Guangxi, China during the first year of antiretroviral therapy (<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>) dynamically, and to understand the influence of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> on oral <jats:italic>Candida<\/jats:italic> status and salivary <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>s expressions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective self\u2010controlled study was carried to observe the dynamic changes of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4<jats:sup>+<\/jats:sup> T cell counts, oral <jats:italic>Candida<\/jats:italic> carriages and salivary <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20102,3 expressions in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content> patients during the first year of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>. A total of 90 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content> patients were enrolled and were examined at the baseline, 3rd, 6th, 12th month of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>. Thirty healthy individuals were enrolled as control. Peripheral blood, oral rinse sample, and unstimulated whole saliva were collected to test <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4<jats:sup>+<\/jats:sup> T cell counts, oral <jats:italic>Candida<\/jats:italic> carriages, and <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20102,3 expressions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the first year of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> CD<\/jats:styled-content>4<jats:sup>+<\/jats:sup> T cell counts increased significantly. However, oral <jats:italic>Candida<\/jats:italic> carriages and oral candidiasis decreased significantly, and salivary <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20102 expressions in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content> patients decreased gradually, salivary <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20103 levels were highly variable. Salivary <jats:styled-content style=\"fixed-case\">hBD<\/jats:styled-content>\u20102 concentrations were positively related to oral <jats:italic>Candida<\/jats:italic> carriages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The incidence of oral candidiasis among <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content> patients gradually decreased due to the immune reconstruction of <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>. Salivary defensins might play an important role in <jats:italic>Candida<\/jats:italic>\u2010host interaction in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content> patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/odi.12847","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T16:33:12Z","timestamp":1520008392000},"page":"964-971","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Salivary human beta\u2010defensins affected by oral <i>Candida<\/i> status in Chinese <scp>HIV<\/scp>\/<scp>AIDS<\/scp> patients undergoing <scp>ART<\/scp>"],"prefix":"10.1111","volume":"24","author":[{"given":"Z","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"},{"name":"Guangxi Key Laboratory of AIDS Prevention and Treatment Guangxi Medical University  Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention (CDC)  Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-1231","authenticated-orcid":false,"given":"R","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Periodontics and Oral Medicine College of Stomatology Guangxi Medical University  Nanning Guangxi China"},{"name":"Guangxi Key Laboratory of AIDS Prevention and Treatment Guangxi Medical University  Guangxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"AIDS(2017).Guidelines for prevention and treatment of opportunistic infections in HIV\u2010infected adults and adolescents. Retrieved fromhttps:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf."},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1601-0825.2002.1o816.x","article-title":"Saliva\u2013the defender of the oral cavity","volume":"8","author":"Amerongen A. V.","year":"2002","journal-title":"Oral Diseases"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf233"},{"key":"e_1_2_7_5_1","first-page":"126","article-title":"Isolation of a T\u2010lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983","volume":"56","author":"Barre\u2010Sinoussi F.","year":"2004","journal-title":"Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2002.120804"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20111454"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02707.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32834970d8"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/154405910508400509"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2017.43.1.29"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0956462414548906"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000713"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/314887"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.09.025"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-101416-041734"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12192"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.3.1024-1029.2004"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/1545109711423444"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2015.02.015"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2442"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005663"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946201759029"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2801"},{"key":"e_1_2_7_26_1","first-page":"1025","article-title":"Human beta\u2010defensin\u20102 in oral cancer with opportunistic Candida infection","volume":"24","author":"Meyer J. E.","year":"2004","journal-title":"Anticancer Research"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2017.1317579"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2012.01183.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.12-0780"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.047522-0"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/262471"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200311070-00001"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.4.729-759.2004"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-2317-7"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1986.tb00646.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2002.1o770.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.22.14318-14329.2005"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3883-3888.2005"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2001.118902"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.069773-0"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.02.020"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.10.004"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.341-350.2002"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00007"},{"key":"e_1_2_7_45_1","unstructured":"WHO(2013).Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva."},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-8"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24177"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fodi.12847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/odi.12847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T01:17:01Z","timestamp":1694999821000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/odi.12847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1111\/odi.12847"],"URL":"https:\/\/doi.org\/10.1111\/odi.12847","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"2017-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}